Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 12.0B | 12.4B | 12.7B | 12.9B |
Cost of revenue | 11.4B | 12.1B | 12.3B | 12.5B |
Gross profit | 620M | 341M | 446M | 468M |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | 100M | 94M | 98M | 93M |
Other operating expenses | — | — | — | — |
Operating income | 520M | 247M | 348M | 375M |
Non operating interest income | ||||
Income | 25M | 23M | 23M | 19M |
Expense | 127M | 112M | 113M | 111M |
Other income expense | 148M | 7M | 99M | 109M |
Pretax income | 566M | 165M | 357M | 392M |
Tax provision | 50M | 45M | 45M | 62M |
Net income | 516M | 120M | 312M | 330M |
Basic EPS | 0.5 | 0.0 | 0.2 | 0.3 |
Diluted EPS | 0.5 | 0.0 | 0.2 | 0.3 |
Basic average shares | 704M | 704M | 702M | 701M |
Diluted average shares | 704M | 704M | 702M | 701M |
EBITDA | 911M | 682M | 728M | 757M |
Net income from continuing op. | 516M | 120M | 312M | 330M |
Minority interests | -73M | -84M | -92M | -80M |
Preferred stock dividends | 0 | -1M | 0 | 7M |